Swiss Paraplegic Research
Nottwil, Canton of Lucerne, 6207, Switzerland
NCT Number: NCT02459028
Background:
Chronic pain is one of the most burdensome potential consequences of a physical disability, such as spinal cord injury (SCI). Estimates of the incidence of chronic pain in SCI range between 65 - 80%. A recent pilot-study of a computer-based tailored positive psychology intervention showed a significant reduction in pain intensity, pain interference, pain catastrophizing and depression and an enhancement of subjective well-being and control over pain in persons with chronic pain secondary to a physical disability.
Study Objective:
Objective 1: To determine the efficacy of a tailored positive psychology intervention (T3P) in a community-based, single-blind, randomized, controlled, parallel group trial on subjective well-being and pain in individuals with chronic pain secondary to SCI.
Hypothesis 1: T3P will result in (1) greater immediate and long-lasting increase in subjective well-being, and perceived control over pain and (2) greater immediate and long-lasting decrease in depression, pain intensity, pain interference and catastrophizing, relative to an active control treatment.
Specific aim 1: To increase the understanding of the mechanisms underlying T3P by determining potential mediation effects.
Hypothesis 2: (1) Pain catastrophizing and pain control mediate the effect of T3P on pain intensity, and (2) positive and negative affect mediate the effect of T3P on life satisfaction and depression.
Objective 2: To identify for whom T3P is most effective by exploring potential moderator effects.
Study Design:
The proposed study is a single-blind, randomized, controlled trial with a parallel group design to determine the effects and mechanisms of T3P in a Swiss community sample of persons with chronic pain secondary to SCI.
Looking for future studies?
Notify Me16 year–100 year
All sexes
Interventional
Phase 2
Nottwil, Canton of Lucerne, 6207, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention group: Participants are instructed to practice 4 out of 10 differentPositive Psychology Exercises (Gratitude, Optimism, Act of Kindness, Social Relations, Forgiveness, Flow, Savoring, Goals, Spirituality, Taking Care of the Body) for at least 15 minutes, at least one day every week including on "bad" days (defined as days with higher than average levels of pain intensity or feeling "down in the dumps") for 8 weeks.
Control group: Control Exercise (Attention Training): Participants assigned to the control group are instructed to be more attentive to their surroundings and write about three specific events or activities from the past 7 days for at least 15 minutes once a week for 8 weeks. This condition is designed to control for the effects of time and participation in an intervention activity.
Time frame: Baseline (Pre-treatment)
Pain Numeric Rating Scale (0-10)
Time frame: Mid-treatment (at 4 weeks)
Pain Numeric Rating Scale (0-10)
Time frame: Post-treatment (at 8 weeks)
Pain Numeric Rating Scale (0-10)
Time frame: Follow-up (at 20 weeks or at 3 months after post-treatment)
Pain Numeric Rating Scale (0-10)
Swiss Paraplegic Research, Nottwil
Network
A Phase II, Community-based, Single-blinded, Randomized Controlled, Parallel-group Trial to Assess the Effects of a Tailored Positive Psychology Intervention on Chronic Pain and Well-being in Individuals With Spinal Cord Injury
Acronym: T3P
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05236933
Behavior, Central Nervous System Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT02262234
Central Nervous System Diseases, Chronic Pain
West Orange, New Jersey, United States
View Trial DetailsNCT01599767
Central Nervous System Diseases, Chronic Pain
Boston, Massachusetts, United States
View Trial DetailsNCT01800604
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Seattle, Washington, United States
View Trial Details